Literature DB >> 31096876

A seed motif for target RNA capture enables efficient immune defence by a type III-B CRISPR-Cas system.

Saifu Pan1, Qi Li1, Ling Deng2, Suping Jiang1, Xuexia Jin1, Nan Peng1, Yunxiang Liang1, Qunxin She1,2, Yingjun Li1.   

Abstract

CRISPR-Cas systems provide an adaptive defence against foreign nucleic acids guided by small RNAs (crRNAs) in archaea and bacteria. The Type III CRISPR systems are reported to carry RNase, RNA-activated DNase and cyclic oligoadenylate (cOA) synthetase activity, and are significantly different from other CRISPR systems. However, detailed features of target recognition, which are essential for enhancing target specificity remain unknown in Type III CRISPR systems. Here, we show that the Type III-B Cmr-α system in S. islandicus generates two constant lengths of crRNA independent of the length of the spacer. Either mutation at the 3'-end of crRNA or target truncation greatly influences the target capture and cleavage by the Cmr-α effector complex. Furthermore, we found that cleavage at the tag-proximal site on the target RNA by the Cmr-α RNP complex is delayed relative to the other sites, which probably provides Cas10 more time to function as a guard against invaders. Using a mutagenesis assay in vivo, we discovered that a seed motif located at the tag-distal region of the crRNA is required by Cmr1α for target RNA capture by the Cmr-α system thereby enhancing target specificity and efficiency. These findings further refine the model for immune defence of Type III-B CRISPR-Cas system, commencing on capture, cleavage and regulation.

Entities:  

Keywords:  CRISPR-Cas; III-B Cmr system; Sulfolobus islandicus; seed sequence; target capture

Mesh:

Substances:

Year:  2019        PMID: 31096876      PMCID: PMC6693533          DOI: 10.1080/15476286.2019.1618693

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  74 in total

1.  Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site.

Authors:  Asma Hatoum-Aslan; Inbal Maniv; Luciano A Marraffini
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.

Authors:  Takuo Osawa; Hideko Inanaga; Chikara Sato; Tomoyuki Numata
Journal:  Mol Cell       Date:  2015-04-23       Impact factor: 17.970

3.  A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems.

Authors:  Migle Kazlauskiene; Georgij Kostiuk; Česlovas Venclovas; Gintautas Tamulaitis; Virginijus Siksnys
Journal:  Science       Date:  2017-06-29       Impact factor: 47.728

4.  Structure of an RNA silencing complex of the CRISPR-Cas immune system.

Authors:  Michael Spilman; Alexis Cocozaki; Caryn Hale; Yaming Shao; Nancy Ramia; Rebeca Terns; Michael Terns; Hong Li; Scott Stagg
Journal:  Mol Cell       Date:  2013-10-10       Impact factor: 17.970

Review 5.  A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.

Authors:  Ryan N Jackson; Blake Wiedenheft
Journal:  Mol Cell       Date:  2015-05-28       Impact factor: 17.970

6.  Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity.

Authors:  Jing Zhang; Christophe Rouillon; Melina Kerou; Judith Reeks; Kim Brugger; Shirley Graham; Julia Reimann; Giuseppe Cannone; Huanting Liu; Sonja-Verena Albers; James H Naismith; Laura Spagnolo; Malcolm F White
Journal:  Mol Cell       Date:  2012-01-05       Impact factor: 17.970

7.  Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers.

Authors:  Soley Gudbergsdottir; Ling Deng; Zhengjun Chen; Jaide V K Jensen; Linda R Jensen; Qunxin She; Roger A Garrett
Journal:  Mol Microbiol       Date:  2010-11-18       Impact factor: 3.501

8.  Detection and characterization of spacer integration intermediates in type I-E CRISPR-Cas system.

Authors:  Zihni Arslan; Veronica Hermanns; Reinhild Wurm; Rolf Wagner; Ümit Pul
Journal:  Nucleic Acids Res       Date:  2014-06-11       Impact factor: 16.971

9.  A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction.

Authors:  Wenyuan Han; Yingjun Li; Ling Deng; Mingxia Feng; Wenfang Peng; Søren Hallstrøm; Jing Zhang; Nan Peng; Yun Xiang Liang; Malcolm F White; Qunxin She
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

10.  Multiple nucleic acid cleavage modes in divergent type III CRISPR systems.

Authors:  Jing Zhang; Shirley Graham; Agnes Tello; Huanting Liu; Malcolm F White
Journal:  Nucleic Acids Res       Date:  2016-01-21       Impact factor: 16.971

View more
  11 in total

1.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

Review 2.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

3.  Reprogramming CRISPR-Mediated RNA Interference for Silencing of Essential Genes in Sulfolobales.

Authors:  Erika Wimmer; Isabelle Anna Zink; Christa Schleper
Journal:  Methods Mol Biol       Date:  2022

Review 4.  CRISPR-Cas adaptive immune systems in Sulfolobales: genetic studies and molecular mechanisms.

Authors:  Zhenxiao Yu; Suping Jiang; Yuan Wang; Xuhui Tian; Pengpeng Zhao; Jianan Xu; Mingxia Feng; Qunxin She
Journal:  Sci China Life Sci       Date:  2020-10-29       Impact factor: 6.038

Review 5.  Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects.

Authors:  Yingjun Li; Nan Peng
Journal:  Front Microbiol       Date:  2019-10-25       Impact factor: 5.640

6.  Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems.

Authors:  Pengjun Xia; Anirudha Dutta; Kushol Gupta; Mona Batish; Vijay Parashar
Journal:  J Biol Chem       Date:  2022-01-14       Impact factor: 5.157

7.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

Review 8.  RNA: interactions drive functionalities.

Authors:  Xiaofeng Dai; Shuo Zhang; Kathia Zaleta-Rivera
Journal:  Mol Biol Rep       Date:  2019-12-14       Impact factor: 2.316

Review 9.  Heavily Armed Ancestors: CRISPR Immunity and Applications in Archaea with a Comparative Analysis of CRISPR Types in Sulfolobales.

Authors:  Isabelle Anna Zink; Erika Wimmer; Christa Schleper
Journal:  Biomolecules       Date:  2020-11-06

10.  Comparative CRISPR type III-based knockdown of essential genes in hyperthermophilic Sulfolobales and the evasion of lethal gene silencing.

Authors:  Isabelle Anna Zink; Thomas Fouqueau; Gabriel Tarrason Risa; Finn Werner; Buzz Baum; Udo Bläsi; Christa Schleper
Journal:  RNA Biol       Date:  2020-09-21       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.